Asset Publisher

< Back to Final Blue Advantage Medical Policies page

Final Policies: F - J

Policy # Policy Title View
BA-472 Fecal Calprotectin Testing
BA-584 Fecal Microbiota Transplantation
BA-231 Fetal Echocardiography and Magnetocardiography
BA-554 Fetal RhD Genotyping Using Maternal Plasma
BA-233 First-Trimester Detection of Down Syndrome Using Fetal Ultrasound Markers Combined with Maternal Serum Assessment
BA-148 Gastric Electrical Stimulation
BA-585 Gene Expression Profiling for Uveal Melanoma
BA-114 Gynecomastia Surgery
BA-258 Helicobacter Pylori Testing
BA-485 Hematopoietic Cell Transplantation for Autoimmune Diseases
BA-153 Hip Resurfacing
BA-264 HIV Genotyping and Phenotyping
BA-548 Identification of Microorganisms Using Nucleic Acid Probes
BA-145 Implantable Bone Conduction and Bone-Anchored Hearing Aids (BAHA)
BA-080 Implantation of Intrastromal Corneal Ring Segments (ICRS, INTACS)
BA-097 In Vitro Chemoresistance and Chemosensitivity Assays
BA-379 Ingestible pH and Pressure Capsule
BA-440 Inhaled Nitric Oxide
BA-120 Intraductal Biopsy - Breast Duct Endoscopy
BA-238 Intratympanic Dexamethasone for the Treatment of Ménière’s Disease and or Sudden Hearing Loss
BA-359 Intravenous Antibiotic Therapy and Associated Diagnostic Testing for Lyme Disease
BA-185 Isolated Limb Perfusion-Infusion for Malignant Melanoma
BA-345 Joint Manipulation under Anesthesia (Excluding Spine)